Product news from the 04/10/07 news brief
The FDA announced the approval of the Cangene Corporation’s HepaGam B for the prevention of hepatitis B reinfection in certain ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.